All sites C00-96,D32-33,D42-43,D45-47,D76 315 86.6 3.9 4.8 0.5 4.2
Mouth, pharynx C00-14 4 88.9 - - - 11.1
  Lip C00 0 100.0 - - - -
  Tongue C02 1 75.0 - - - 25.0
  Mouth, other C03-06 2 88.9 - - - 11.1
  Salivary glands C07-08 1 100.0 - - - -
  Pharynx C01,C09-14 0 100.0 - - - -
Digestive organs C15-26 68 80.0 1.2 10.3 1.5 7.1
  Oesophagus C15 1 60.0 - - 20.0 20.0
  Stomach C16 8 95.2 - 2.4 - 2.4
  Small intestine C17 1 75.0 - - - 25.0
  Colon C18 23 93.8 0.9 1.8 0.9 2.7
  Rectum, rectosigmoid C19-20 14 94.2 - 2.9 - 2.9
  Anus C21 1 100.0 - - - -
  Liver C22 5 52.2 4.3 34.8 - 8.7
  Gallbladder, bile ducts C23-24 4 61.9 9.5 19.0 - 9.5
  Pancreas C25 11 46.4 - 32.1 3.6 17.9
  Other digestive organs C26 1 - - - 33.3 66.7
Respiratory organs C30-39 17 58.6 21.8 11.5 1.1 6.9
  Nose, sinuses C30-31 0 100.0 - - - -
  Larynx, epiglottis C32 1 100.0 - - - -
  Lung, trachea C33-34 16 57.5 23.8 12.5 1.3 5.0
  Mediastinum, pleura C38 0 - - - - 100.0
Bone C40-41 0 50.0 - 50.0 - -
Melanoma of the skin C43 11 100.0 - - - -
Skin, non-melanoma C44 8 97.4 - - - 2.6
Mesothelioma C45 0 100.0 - - - -
Autonomic nervous system C47 - - - - - -
Soft tissues C48-49 2 100.0 - - - -
Breast C50 95 98.7 - 0.2 0.2 0.8
Female genital organs C51-58 44 93.2 4.1 1.8 - 0.9
  Cervix uteri C53 3 82.4 11.8 5.9 - -
  Corpus uteri C54 24 99.2 - - - 0.8
  Uterus, other C55,C58 - - - - - -
  Ovary C56 13 82.8 10.9 4.7 - 1.6
  Other female genital C51-52,C57 4 100.0 - - - -
Urinary organs C64-68 12 90.2 - 3.3 1.6 4.9
  Kidney C64 7 91.4 - 5.7 2.9 -
  Bladder and urinary tract2 C65-68 5 88.5 - - - 11.5
Eye C69 1 66.7 - 33.3 - -
Brain, central nervous system C70-72,D32-33,D42-43 11 85.7 - 8.9 - 5.4
Thyroid gland C73 4 100.0 - - - -
Other endocrine glands C74-75 - - - - - -
Illdefined or unknown C76,C80 12 43.3 16.7 23.3 - 16.7
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 25 73.2 15.7 1.6 - 9.4
  Hodgkin lymphoma C81 1 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 10 96.2 - - - 3.8
  Malignant immunoproliferative diseases C88 0 100.0 - - - -
  Myeloma and other plasma cell tumors C90 4 57.1 19.0 9.5 - 14.3
  Leukaemia C91-95 7 57.1 31.4 - - 11.4
  Myelodysplastic syndromes D46 1 20.0 40.0 - - 40.0
  Myeloproliferaitive neoplasms D45,D47 2 50.0 37.5 - - 12.5
Not included above
  Carcinoma in situ of the breast D05 5 100.0 - - - -
  Cervix uteri, non-invasive neoplasms 10 100.0 - - - -
  Borderline tumour of the ovary D39 4 100.0 - - - -
  Basal cell carcinoma of the skin 98 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.